Bioluminescence-Based High-Throughput Screen Identifies Pharmacological Agents That Target Neurotransmitter Signaling in Small Cell Lung Carcinoma

Open Access

Peer-reviewed

Research Article

Ma. Reina D. Improgo,

Affiliation Brudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America
⨯
Christopher W. Johnson,

Affiliation Brudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America
⨯
Andrew R. Tapper,

Affiliation Brudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America
⨯
Paul D. Gardner

* E-mail: paul.gardner@umassmed.edu

Affiliation Brudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America
⨯

Reader Comments (0)

Small cell lung cancer
Is the Subject Area "Small cell lung cancer" applicable to this article?

Thanks for your feedback.
Luciferase assay
Is the Subject Area "Luciferase assay" applicable to this article?

Thanks for your feedback.
Serotonin
Is the Subject Area "Serotonin" applicable to this article?

Thanks for your feedback.
Luciferase
Is the Subject Area "Luciferase" applicable to this article?

Thanks for your feedback.
Neurotransmitter receptor signaling
Is the Subject Area "Neurotransmitter receptor signaling" applicable to this article?

Thanks for your feedback.
Drug screening
Is the Subject Area "Drug screening" applicable to this article?

Thanks for your feedback.
Cell viability testing
Is the Subject Area "Cell viability testing" applicable to this article?

Thanks for your feedback.
Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.